3:58 PM
 | 
Dec 10, 2018
 |  BC Extra  |  Company News

Genentech's Anderson to succeed O'Day at Roche

Genentech Inc. CEO Bill Anderson will succeed Daniel O’Day as the CEO of the pharmaceuticals division of Roche (SIX:ROG; OTCQX:RHHBY) on Jan. 1. O'Day is leaving Roche to head Gilead Sciences Inc. (NASDAQ:GILD) as chairman and CEO on March 1 (see "Roche's O'Day to...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >